Lunai Bioworks Expands Parkinson's Platform Through Exclusive Tanaist Agreement
LNAI•Exclusive Parkinson's technology agreement
Lunai Bioworks Inc. said it is expanding its Parkinson's platform through an exclusive agreement with Tanaist.
- Lunai Bioworks receives exclusive rights to Tanaist cellular phenotyping technology for Parkinson's.
- Lunai Bioworks will own collaboration-generated results and intellectual property.
